CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

ChristianaCare

Richard Choi, Co-Chief, Neurocritical Care

Beneath The Brink: A Critical Look At The American Healthcare System

Richard Choi

Richard Choi


Many consider the American healthcare system to be the best in the world thanks to its fast-paced research, evidence-based strategies, novel therapies, and advancements in pharmaceutics and technology. Yet we also have a life expectancy that, for the first time in recorded history, has trended downwards since the COVID-19 pandemic, maternal mortality rates that are dismal compared to many other developed countries, and many surveys rank the U.S. healthcare as far inferior to many developed countries. Most worrisome, however, is how our healthcare system is funded and the downstream effects that this has on the delivery of healthcare on the front line.


Part of the problem is how we fund healthcare. Though Medicare and Medicaid only cover those over the age of 65 (Medicare) or those who live below a certain income level (Medicaid), over 150 million Americans are covered by them. The Affordable Care Act (ACA) covers an additional 20 million people, and CHIP covers almost 10 million children.


 

In its current format, unless something gives, our healthcare system is headed toward the edge of a precipice


The money spent on these services comes from taxpayers, like you or I, and has always gone to the private sector – we use it to pay private health insurances or healthcare systems, and many of which have fiduciary responsibilities towards their stockholders. Let that sink in: we are indirectly funneling taxpayer money to pay dividends to the stockholders of these companies.



In 2023, almost half of our $6.3 trillion federal budget went to pay for Social Security and Health insurance (Medicare, Medicaid, CHIP, ACA). This massive amount of healthcare spending is expected to continue to grow every passing year as the baby boomers continue to age and are being joined by Gen X. In 2020, 17 percent of Americans who are aged 65 or older accounted for 37 percent of all personal healthcare spending. Since our lifespan has been increasing overall - good news for all of us - it also means that our healthcare costs will continue to skyrocket.


At the same time, we are still feeling the lingering effects that the COVID-19 pandemic has on healthcare workers. Many in healthcare decided to leave medicine after experiencing extreme burn-out, and many Gen Z’s who experience healthcare become disillusioned with it, have many other better alternatives to make money, and would prefer not to have to sacrifice anything for their job. Sacrifice - from not being at home with our families on nights, weekends and holidays; from staying late to take care of our sick patients, from having to work additional shifts because we are short on staff – is something that we in our industry used to take pride on yet is not something that the next (smarter?) generation is willing to undergo.


The combination of fewer healthcare workers and fewer entering the field means labor costs also climb. In the meantime, hospitals are faced with supplies that are rising in cost due to inflation, as well as diminishing reimbursements from both government and private healthcare payors. The agglomeration of rising healthcare costs, labor costs, supply costs and diminishing reimbursement is why hospital profit margins are going down the drain. This has led to the acceleration of hospital closures in the last decade. Hospitals, however, are not the only healthcare providers that are affected: these same problems affect outpatient offices, and our current ability to access healthcare is worse now than it was pre-COVID-19.


Now, more people show up in the ER, being far sicker than they would have been had they had better access to healthcare. Combine a sicker patient who has fewer options of where to go, and the effect is unprecedented hospital volumes. Over the past several years, we have, at times, experienced impossible volumes, with far sicker patients and nowhere to place them. All while facing severe staffing and supply shortages, which means we must do much more with far less. Because those who entered this industry did so with the conviction that they wanted to help others, the need for sacrifice is now more necessary than ever, and this continues to drive others out of the field, compounding the problem.


In the meantime, the federal and state governments continue to attempt to enact laws that would hurt hospital and healthcare worker compensation. In Delaware, House Bill 350 has been presented, which would allow a Review Board to determine the annual hospital budget, potentially slashing hundreds of millions that are currently used to keep hospitals open.


In its current format, unless something gives, our healthcare system is headed toward the edge of a precipice.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://neuroscience.lifesciencesreview.com/leadership-perspective/beneath-the-brink-a-critical-look-at-the-american-healthcare-system-nwid-2171.html